Transduction of Psychological Stress into Systematic Inflammation by Mitochondrial DNA Signaling

通过线粒体 DNA 信号传导将心理压力转变成系统性炎症

基本信息

项目摘要

PROJECT SUMMARY Systemic inflammation is believed to contribute to the damaging health effects of psychological stress. In the laboratory setting, a single acute bout of socioevaluative stress leads to a delayed elevation of pro- inflammatory cytokines in healthy adults. However, the biological mechanisms by which psychological stress is transduced into inflammation is not well understood. A cellular component known to contribute to stress signaling is the mitochondrion – a bacteria-derived organelle with its own genome, the mitochondrial DNA (mtDNA). Recent evidence has demonstrated that various stressors induce the release of mitochondria- derived signaling molecules, or mitokines. Mitokines travel systemically and modulate central physiological processes, including immune cell function and the production of pro-inflammatory cytokines. One key mitokine is circulating cell-free mtDNA (ccf-mtDNA), which arises from mitochondrial extrusion of mtDNA, is recognized by the toll-like receptor 9 (TLR-9), and leads to pro-inflammatory cytokine production in animal and human cells. Our preliminary data showed that ccf-mtDNA release, but not ccf-nuclear DNA, is acutely induced following a brief experimental psychological stress in humans. Thus, we suggest that ccf-mtDNA may be a missing link in the stress-inflammation cascade. In parallel, imaging and molecular studies on cellular systems suggests that ccf-mtDNA may be rapidly induced by primary neuroendocrine stress mediators, including glucocorticoids. This proposal will use an experimental socio-evaluative stress task, counterbalanced with a control no-stress visit for each participant, to map the kinetics of reactivity and recovery in ccf-mtDNA and other stress mediators in healthy women and men. Aim 1 will establish: i) the magnitude and kinetics of ccf- mtDNA release; ii) the specificity of this response compared to nuclear DNA; iii) examine potential sex differences in this process; and iv) statistically test ccf-mtDNA as a mediator of the subsequent increase in pro- inflammatory cytokines. In Aim 2, cellular and molecular studies will determine: i) whether primary glucocorticoid and catecholamine stress hormones are sufficient to trigger ccf-mtDNA release in primary human cultured cells and isolated leukocytes; ii) image in living cells mtDNA release in response to stress signaling; and iii) document physical changes in mtDNA structure that contribute to ccf-mtDNA release. Finally, Aim 3 will establish: i) the capacity of ccf-mtDNA from peak ccf-mtDNA serum to activate cytokine production in target cells; ii) the structural form and accessibility of ccf-mtDNA in human serum (from Aim 1); and iii) the dependency on TLR-9 for immune activation. Overall, these studies will contribute mechanistic evidence for a novel mitochondria-mediated mechanisms for transducing stress into inflammation in humans. Outcomes from this work will identify new potential targets to improve stress-related mental health and inflammatory disorders.
项目摘要 据信系统性炎症会导致心理压力的健康影响。在 实验室环境,一次社会评估应力的一次急性急性发作导致促进 健康成年人的炎性细胞因子。但是,心理压力的生物学机制 转导为炎症尚不清楚。已知有助于应力的细胞成分 信号传导是线粒体 - 具有其自身基因组的细菌衍生细胞体,线粒体DNA (mtDNA)。最近的证据表明,各种压力诱导线粒体的释放 派生的信号分子或有丝分子。有丝分子系统地旅行并调节中央生理 过程,包括免疫细胞功能和促炎细胞因子的产生。一个关键的有丝分裂因子 是由mtDNA的线粒体扩展产生的循环无细胞mtDNA(CCF-MTDNA)。 通过Toll样受体9(TLR-9),并导致动物和人类的促炎性细胞因子产生 细胞。我们的初步数据表明,CCF-MTDNA释放而不是CCF - 核DNA是急性诱导的 在人类中短暂的实验心理压力之后。那我们建议CCF-MTDNA可能是 缺少应力炎症级联中的链接。同时,对细胞系统的成像和分子研究 表明CCF-MTDNA可能是由原发性神经内分泌应激介体迅速诱导的,包括 糖皮质激素。该建议将使用实验性的社会评估压力任务,与 控制每个参与者的无压力访问,以绘制CCF-MTDNA中反应性和恢复的动力学 健康男女的其他压力介体。 AIM 1将建立:i)CCF-的大小和动力学 mtDNA释放; ii)与核DNA相比,这种反应的特异性; iii)检查潜在的性别 这个过程的差异; iv)统计测试CCF-MTDNA作为随后增加的介体 炎症细胞因子。在AIM 2中,细胞和分子研究将确定:i) 糖皮质激素和儿茶酚胺胁迫恐怖足以触发初级中的CCF-MTDNA释放 人培养的细胞和分离的白细胞; ii)活细胞中的图像mtDNA响应应力而释放 信号传导; iii)记录有助于CCF-MTDNA释放的mtDNA结构的物理变化。最后, AIM 3将建立:i)CCF-MTDNA从峰CCF-MTDNA血清激活细胞因子在中的能力 靶细胞; ii)CCF-MTDNA在人血清中的结构形式和可及性(来自AIM 1);和iii) 对TLR-9的依赖性免疫激活。总体而言,这些研究将为A提供机理证据 新型的线粒体介导的机制,将应激转换为人类炎症。结果 这项工作将确定新的潜在目标,以改善与压力相关的心理健康和炎症性疾病。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Brett A Kaufman其他文献

Brett A Kaufman的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Brett A Kaufman', 18)}}的其他基金

Control of insulin secretion by mitochondrial fusion
通过线粒体融合控制胰岛素分泌
  • 批准号:
    10753730
  • 财政年份:
    2023
  • 资助金额:
    $ 68.36万
  • 项目类别:
Developing intrabody therapeutics for mitochondrial DNA heteroplasmy
开发线粒体 DNA 异质性的体内疗法
  • 批准号:
    10386997
  • 财政年份:
    2022
  • 资助金额:
    $ 68.36万
  • 项目类别:
Developing intrabody therapeutics for mitochondrial DNA heteroplasmy
开发线粒体 DNA 异质性的体内疗法
  • 批准号:
    10585928
  • 财政年份:
    2022
  • 资助金额:
    $ 68.36万
  • 项目类别:
Mitochondrial G-quadruplex structures in health and disease
健康和疾病中的线粒体 G-四链体结构
  • 批准号:
    10428535
  • 财政年份:
    2020
  • 资助金额:
    $ 68.36万
  • 项目类别:
Mitochondrial G-quadruplex structures in health and disease
健康和疾病中的线粒体 G-四链体结构
  • 批准号:
    10221730
  • 财政年份:
    2020
  • 资助金额:
    $ 68.36万
  • 项目类别:
Transduction of Psychological Stress into Systematic Inflammation by Mitochondrial DNA Signaling
通过线粒体 DNA 信号传导将心理压力转变成系统性炎症
  • 批准号:
    10574523
  • 财政年份:
    2019
  • 资助金额:
    $ 68.36万
  • 项目类别:
Transduction of Psychological Stress into Systematic Inflammation by Mitochondrial DNA Signaling
通过线粒体 DNA 信号传导将心理压力转变成系统性炎症
  • 批准号:
    10359137
  • 财政年份:
    2019
  • 资助金额:
    $ 68.36万
  • 项目类别:
Molecular mechanisms of mitochondrial DNA deletion formation
线粒体DNA缺失形成的分子机制
  • 批准号:
    9261548
  • 财政年份:
    2015
  • 资助金额:
    $ 68.36万
  • 项目类别:

相似国自然基金

内皮β3肾上腺素能受体调控线粒体功能参与血管衰老的作用研究
  • 批准号:
    82370408
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
肾上腺素能受体激动剂引起睑板腺功能障碍发病的机制研究
  • 批准号:
    82371024
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
心脏成纤维细胞β2-肾上腺素能受体对心衰小细胞外囊泡释放的作用机制研究
  • 批准号:
    82370276
  • 批准年份:
    2023
  • 资助金额:
    47.00 万元
  • 项目类别:
    面上项目
α1-和β3-肾上腺素能受体的荧光探针可视化研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    52 万元
  • 项目类别:
    面上项目
β2肾上腺素能受体调控皮肤角化细胞活化在慢性重叠型疼痛状态中的机制研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    52 万元
  • 项目类别:
    面上项目

相似海外基金

Rhinovirus, airway smooth muscle, and mechanisms of irreversible airflow obstruction
鼻病毒、气道平滑肌和不可逆气流阻塞机制
  • 批准号:
    10735460
  • 财政年份:
    2023
  • 资助金额:
    $ 68.36万
  • 项目类别:
An Enzyme-Based Antidote for Acute Nicotine Toxicity
一种基于酶的急性尼古丁中毒解毒剂
  • 批准号:
    10790758
  • 财政年份:
    2023
  • 资助金额:
    $ 68.36万
  • 项目类别:
Development of small molecule Protease-activated-receptor-2 antagonists as oral asthma therapeutics
开发小分子蛋白酶激活受体 2 拮抗剂作为口服哮喘治疗药物
  • 批准号:
    10766584
  • 财政年份:
    2023
  • 资助金额:
    $ 68.36万
  • 项目类别:
Diversity Supplement to Beta-Adrenergic Modulation of Drug Cue Reactivity: Neural and Behavioral Mechanisms
药物提示反应性β-肾上腺素能调节的多样性补充:神经和行为机制
  • 批准号:
    10838177
  • 财政年份:
    2022
  • 资助金额:
    $ 68.36万
  • 项目类别:
Beta-Adrenergic Modulation of Drug Cue Reactivity: Neural and Behavioral Mechanisms
药物提示反应性的β-肾上腺素调节:神经和行为机制
  • 批准号:
    10446411
  • 财政年份:
    2022
  • 资助金额:
    $ 68.36万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了